151 related articles for article (PubMed ID: 29099265)
1. Analysis of defective protein ubiquitylation associated to adriamycin resistant cells.
Lang V; Aillet F; Xolalpa W; Serna S; Ceccato L; Lopez-Reyes RG; Lopez-Mato MP; Januchowski R; Reichardt NC; Rodriguez MS
Cell Cycle; 2017; 16(24):2337-2344. PubMed ID: 29099265
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Mol Cell Biol; 2003 Apr; 23(7):2463-75. PubMed ID: 12640129
[TBL] [Abstract][Full Text] [Related]
3. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance.
Fujita T; Washio K; Takabatake D; Takahashi H; Yoshitomi S; Tsukuda K; Ishibe Y; Ogasawara Y; Doihara H; Shimizu N
Int J Cancer; 2005 Nov; 117(4):670-82. PubMed ID: 15945097
[TBL] [Abstract][Full Text] [Related]
6. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
[TBL] [Abstract][Full Text] [Related]
7. Efficient monitoring of protein ubiquitylation levels using TUBEs-based microarrays.
Serna S; Xolalpa W; Lang V; Aillet F; England P; Reichardt N; Rodriguez MS
FEBS Lett; 2016 Aug; 590(16):2748-56. PubMed ID: 27410252
[TBL] [Abstract][Full Text] [Related]
8. P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin.
Ma Y; Yuan R; Meng Q; Goldberg ID; Rosen EM; Fan S
Mol Cell Biol Res Commun; 2000 Feb; 3(2):122-8. PubMed ID: 10775510
[TBL] [Abstract][Full Text] [Related]
9. [Immunological effector cells enhance apoptosis induced by adriamycin in a multi-drug resistant human breast cancer cell line].
Shi YJ; Ren HY; Cen XN; Zhu Q; Yu JR
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):188-91. PubMed ID: 16875602
[TBL] [Abstract][Full Text] [Related]
10. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
Tsou SH; Chen TM; Hsiao HT; Chen YH
PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
[TBL] [Abstract][Full Text] [Related]
11. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
13. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
[TBL] [Abstract][Full Text] [Related]
14. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
Chang L; Hu Z; Zhou Z; Zhang H
Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
Chen J; Wang W; Wang H; Liu X; Guo X
Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
[TBL] [Abstract][Full Text] [Related]
17. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function.
Cai Z; Capoulade C; Moyret-Lalle C; Amor-Gueret M; Feunteun J; Larsen AK; Paillerets BB; Chouaib S
Oncogene; 1997 Dec; 15(23):2817-26. PubMed ID: 9419972
[TBL] [Abstract][Full Text] [Related]
18. Effects of geranyl-phloroacetophenone on the induction of apoptosis and chemosensitization of adriamycin-resistant MCF-7 human breast cancer cells.
Cho MY; Park SY; Park S; Lee YR; Kwak MK; Kim JA
Arch Pharm Res; 2012 May; 35(5):911-9. PubMed ID: 22644859
[TBL] [Abstract][Full Text] [Related]
19. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
20. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L
Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
